Melts Pro Selank + Semax Dissolving Strips

A mouth-dissolving film containing Selank and Semax, two peptides approved only in Russia, and only as nasal drops.

The strip contains the same two neuropeptides as the catalog's Selank and Semax vials: Selank, a stabilized tuftsin analog, and Semax, a modified ACTH fragment. Both have been studied for effects on the nervous system when given intranasally. Whether either is absorbed from a mouth strip is unknown.

No study of Selank and Semax given together was found, and no published data exist for either peptide by sublingual or buccal route; all labeling and human data are intranasal. Peptides in the mouth face salivary enzymes and loss by swallowing. For comparison, approved under-the-tongue or oral peptide drugs absorb poorly: sublingual desmopressin, a similar-size peptide, has about 0.25% bioavailability, and oral semaglutide about 0.4–2% even with an absorption enhancer. No enhancer is disclosed for this strip.

Component cautions apply; Semax's Russian label lists anxiety disorders and seizure history as contraindications, while Selank is marketed for anxiety, so the pairing mixes opposing label positions. Mouth irritation and reactions to undisclosed excipients are unstudied, and the unclear strength means exposure cannot be known. Neither component has data in pregnancy, breastfeeding or under 18.

Neither peptide is FDA-approved. Selank's compounding nomination was withdrawn; Semax received an 8–5–1 FDA advisory committee vote in July 2026 recommending 503A bulks listing, but the vote is advisory and no final rule had followed as of October 2026, so neither is compoundable. Neither is named on the 2026 WADA list, and both are approved in Russia.